FDA Clearance Tracker · P000037-S018
ON-X ASCENDING AORTIC PROSTHESIS
Last checked: Nov 20, 2026Latest source record: Jan 14, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Jan 14, 2011
Approved
Time to decision
375 days
Received Jan 4, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P000037-S018
- Device name
- ON-X ASCENDING AORTIC PROSTHESIS
- Applicant
- On-X Life Technologies, Inc.
- Applicant location
- Kennesaw, GA
- Received
- Jan 4, 2010
- Decided
- Jan 14, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P000037
Device type
- Device type
- HEART-VALVE, MECHANICAL (LWQ)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT VASCUTEK, LTD., SCOTLAND, GREAT BRITAIN (UK). ALSO APPROVAL FOR A VALVED CONDUIT. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER HE TRADE NAME ON-X ASCENDING AORTIC PROSTHESIS AND IS INDICATED FOR THE REPLACEMENT OF A DISEASED, DAMAGED, OR MALFUNCTIONING NATIVE OR PROSTHETIC HEART VALVE IN THE AORTIC POSITION IN CASES THAT INVOLVE AN ASCENDING AORTIC ANEURYSM OR OTHER ASSOCIATED AORTIC DISEASE.
Source documents
Other decisions for On-X Life Technologies, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.